On Wednesday, indices futures are trading higher as the upward trend in equities continues. This morning sees 3rd quarter updates from Next (LON: NXT), GSK (LON: GSK) and Aston Martin (LON: AML), while Wizz Air (LON: WIZZ) reported its half-year report.
Next
- Next reported its trading update on November 2, showing full-price sales up 0.4%.
- Full price sales came in ahead of guidance and were boosted by on particularly strong week, with temperatures dropping and heavier-weight products improving.
- The company is maintaining its guidance for full-year profit before tax at £840 million, up 2.1% versus last year.
- In addition, EPS of 554.5p would be up 4.5% versus last year.
GSK
- GSK’s 3rd quarter results saw strong sales of £7.8 billion.
- Furthermore, the group posted total EPS of 255.9p, primarily reflecting the gain from discontinued operations arising on the demerger of the consumer healthcare business.
- The company raised its 2022 guidance as it expects to deliver sales between 8% and 10%, and adjusted operating profit between 15% and 17%.
Aston Martin
- In Aston Martin’s 3rd quarter results, the company reported year-to-date revenue increased 16% to £857.2 million.
- Meanwhile, revenue for the third quarter was up 33% to £315.5 million.
- The group stated however that supply chain challenges continued to moderate potential growth and impact working capital.
- The company stated they remain on its pathway to achieving its medium-term targets of £2 billion in revenue and £500 million adjusted EBITDA by 2024/25.
Wizz Air
- Finally, Wizz Air announced its half-year report, showing strong revenue and capacity growth in H1.
- Passengers carried jumped to 26.5 million, up 112% from the previous year.
- Revenue surged 149.2% to €2.19 billion, but the company reported an operating loss of €63.8 million.
- Josef Varadi, Wizz Air Chief Executive, stated that the airline was gearing up to operate at 35% higher capacity in the second half versus 2019.